International journal of

ADVANCED AND APPLIED SCIENCES

EISSN: 2313-3724, Print ISSN:2313-626X

Frequency: 12
line decor
  
line decor

 Volume 5, Issue 3 (March 2018), Pages: 53-59

----------------------------------------------

 Original Research Paper

 Title: A study on ALAD (G177C and T168C) and MGP (T-138C) gene polymorphisms associated with lead exposure in subjects from Saudi Arabia

 Author(s): Abjal Pasha Shaik 1, Abbas H. Alsaeed 1, *, A. Sultana 1, M. Faiyaz-Ul-Haque 2, Mikqdad A. Alsaeed 3, Sadia Tabassum 2, Merajuddin Ahmed 2, Sibtain Afzal 4

 Affiliation(s):

 1Department of Clinical Laboratory Sciences, King Saud University, Riyadh, Saudi Arabia
 2Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia
 3King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
 4Prince Naif Centre for Immunology Research, King Saud University, Riyadh, Saudi Arabia

 https://doi.org/10.21833/ijaas.2018.03.008

 Full Text - PDF          XML

 Abstract:

Delta aminolevulinic acid dehydratase (ALAD) gene polymorphisms (rs1139488 – MspI and RsaI in exon 4) and Matrix Gla (g-carboxyglutamic acid) protein T-138C polymorphisms were reported to affect the response of individuals to lead toxicity symptoms. In several previous studies, large inter-ethnic differences in the frequencies of different gene variants have been reported. However, no informational data about the Arab world has been documented. This study was carried out to examine the effects of ALAD and MGP gene polymorphisms on blood lead levels. Method: A total of 127 subjects employed in different professions like battery shops, painting industry and automobile repair shop and plumbers from different parts of Riyadh region, Saudi Arabia. Blood lead levels (BLL), and genotyping, and restriction digestion was performed for each sample. Result: The BLLs in low BLL (<10 μg/dL) group remained well within prescribed safe limits with mean levels of 4.37 µg/dL. In high BLL (>10 μg/dL) group however, the levels were significantly elevated to 18.12 µg/dL (p<0.001). Workers involved in battery acidifying area were found to have high blood lead level (18.70 μg/dL), followed by those involved in plate making process (12.57 μg/dL) and opening and breaking of old batteries (10.77 μg/dL). On the other hand, lead level was found to be as low as <3.3 μg/dL among the workers who were not involved in battery breaking or manufacturing process (administration, drivers and security personnel). Overall, the genotype frequencies of GG and GC+CC for ALAD exon 4 MspI restriction site (G177C) were 96.7% and 3.3%, with allele frequencies of 0.979 (G) and 0.01 (C), respectively. For ALAD exon 4 RsaI restriction site (T168C), the frequency of TT and TC+CC genotypes were 65% and 35% with allele frequency  of 0.779 (T) and 0.220 (C) respectively. For the Matrix Gla (γ-carboxyglutamic acid) gene (MGP) T-138C polymorphism, the variants TC and CC were not detected in this population; all subjects had TT genotype. BLLs for ALAD G177G, ALAD C168C and MGP T-138T genotypes from High BLL group were 18.70, 19.09 and 15.05 μg/dl respectively. 

 © 2018 The Authors. Published by IASE.

 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

 Keywords: ALAD, MGP, Gene polymorphisms, Lead toxicity, Saudi Arabia

 Article History: Received 16 October 2017, Received in revised form 5 January 2018, Accepted 6 January 2018

 Digital Object Identifier: 

 https://doi.org/10.21833/ijaas.2018.03.008

 Citation:

  Shaik AP, Alsaeed AH, Sultana A et al. (2018). A study on ALAD (G177C and T168C) and MGP (T-138C) gene polymorphisms associated with lead exposure in subjects from Saudi Arabia. International Journal of Advanced and Applied Sciences, 5(3): 53-59

 Permanent Link:

 http://www.science-gate.com/IJAAS/2018/V5I3/Shaik.html

----------------------------------------------

 References (30)

  1. Afshin F, Davies JD, Braam LA, Spronk HM, Proudfoot D, Chan S, O'Shaughnessy KM, Weissberg PL, Vermeer C, and Shanahan CM (2001). A polymorphism of the human matrix G-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. The Journal of Biological Chemistry, 276: 32466–32473. https://doi.org/10.1074/jbc.M104909200  PMid:11425864 
  2. Al-Othman AM, Al-Othman ZA, El-Desoky GE, Aboul-Soud MA, Habila MA, and Giesy JP (2013). Lead in drinking water and human blood in Riyadh City, Saudi Arabia. Arabian Journal of Geosciences, 6(8): 3103-3109. https://doi.org/10.1007/s12517-012-0551-4 
  3. Alsaeed AH, Shaik AP, Faiyaz-ul-Haque M, Tabassum S, Alsaeed AM, Alyousef A, and Shaik AS (2017). Evaluation of blood lead levels and their association with haematological and liver function test parameters in Saudi workers from Riyadh region, KSA. Biomedical Research, 28(4): 1781-1785.     
  4. Al-Saleh I, Khalil MA, and Taylor A (1995). Lead, erythrocyte protoporphyrin, and hematological parameters in normal maternal and umbilical cord blood from subjects of the Riyadh region, Saudi Arabia. Archives of Environmental Health: An International Journal, 50(1): 66-73. https://doi.org/10.1080/00039896.1995.9955014  PMid:7717771 
  5. Al-Saleh I, Nester M, Devol E, Shinwari N, and Al-Shahria S (1999). Determinants of blood lead levels in Saudi Arabian schoolgirls. International Journal of Occupational and Environmental Health, 5(2): 107-114. https://doi.org/10.1179/oeh.1999.5.2.107  PMid:10330510 
  6. Al-Saleh IA (1995). Lead exposure in Saudi Arabia and its relationship to smoking. Biometals, 8(3): 243-245. https://doi.org/10.1007/BF00143383  PMid:7647521 
  7. ATSDR (2006). Interaction profile for chlorpyrifos, lead, mercury, and methylmercury. Agency for Toxic Substances and Disease Registry, Atlanta, USA: 54-100. Available online at: https://www.atsdr.cdc.gov     
  8. Bellinger DC (2004). Lead. Pediatrics, 113(4): 1016–1022. PMid:15060194     
  9. Bergdahl IA (1998). Lead-binding proteins-a way to understand lead toxicity?. Analusis, 26(6): 81-83. https://doi.org/10.1051/analusis:199826060081 
  10. Bressler JP and Goldstein GW (1991). Mechanisms of lead neurotoxicity. Biochemical Pharmacology, 41(4): 479-484. https://doi.org/10.1016/0006-2952(91)90617-E 
  11. Cancela L, Hsieh CL, Francke U, and Price PA (1990). Molecular structure, chromosome assignment, and promoter organization of the human matrix Gla protein gene. Journal of Biological Chemistry, 265(25): 15040-15048. PMid:2394711     
  12. CDC (1991). Preventing lead poisoning in young children. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Public Health Service, Atlanta, USA. Available online at: https://www.cdc.gov 
  13. CDC (1997). Adult blood lead epidemiology and surveillance-United States Fourth Quarter 1996. Centers for Disease Control and Prevention, Atlanta, USA. Available online at: https://www.cdc.gov     
  14. ChemIDplus (2005). Lead and lead compounds. CAS No. 7439-92-1, Report on Carcinogens, National Toxicology Program, Department of Health and Human Services, Washington, D.C., USA.     
  15. Eaton DL and Klaassen CD (1996). Principles of toxicology. In: Klaassen CD and Amdur MO (Eds.), Casarett and Doull's toxicology: The basic science of poisons (vol 5): 13-33. McGraw-Hill, New York, USA.     
  16. Hu H, Wu MT, Cheng Y, Sparrow D, Weiss S, and Kelsey K (2001). The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: The normative aging study. Environmental Health Perspectives, 109(8): 827–832. PMid:11564619 PMCid:PMC1240411     
  17. Kelada SN, Shelton E, Kaufmann RB, and Khoury MJ (2001). δ-Aminolevulinic acid dehydratase genotype and lead toxicity: A HuGE review. American Journal of Epidemiology, 154(1): 1-13. https://doi.org/10.1093/aje/154.1.1  PMid:11427399 
  18. Montenegro MF, Barbosa F, Sandrim VC, Gerlach RF, and Tanus-Santos JE (2006a). A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio. Archives of Toxicology, 80(7): 394-398. https://doi.org/10.1007/s00204-005-0056-y  PMid:16341691     
  19. Montenegro MF, Barbosa F, Sandrim VC, Gerlach RF, and Tanus-Santos JE (2006b). Ethnicity affects the distribution of δ-aminolevulinic acid dehydratase (ALAD) genetic variants. Clinica Chimica Acta, 367(1): 192-195. https://doi.org/10.1016/j.cca.2005.12.009  PMid:16445899 
  20. Onalaja AO and Claudio L (2000). Genetic susceptibility to lead poisoning. Environmental Health Perspectives, 108(1): 23-28. https://doi.org/10.1289/ehp.00108s123  PMid:10698721 PMCid:PMC1637782     
  21. Osorio AM and Melius J (1995). Lead poisoning in construction. Occupational Medicine (Philadelphia, Pa.), 10(2): 353-361. PMid:7667745     
  22. Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, and Williamson MK (2002). Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix γ-carboxyglutamic acid protein in the serum of etidronate-treated rats. Journal of Biological Chemistry, 277(6): 3926-3934. https://doi.org/10.1074/jbc.M106366200  PMid:11724771 
  23. RTECS (2007). Lead. Registry of Toxic Effects on Chemical Substances, National Institute of Occupational Safety and Health, MDL Information Systems, Inc., San Ramon, USA.     
  24. Schwartz BS, Lee BK, Stewart W, Ahn KD, Springer K, and Kelsey K (1995). Associations of δ-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. American Journal of Epidemiology, 142(7): 738-745. https://doi.org/10.1093/oxfordjournals.aje.a117705  PMid:7572945 
  25. Shaik AP and Jamil K (2008). A study on the molecular analysis of ALAD gene polymorphisms. Toxicology and Industrial Health, 24(7): 501-506. https://doi.org/10.1177/0748233708095770  PMid:19028776     
  26. Shaik AP and Jamil K (2009). Polymorphisms in MGP gene and their association with lead toxicity. Toxicology Mechanisms and Methods, 19(3): 209-213. https://doi.org/10.1080/15376510802488181  PMid:19730704 PMCid:PMC2736540 
  27. Shanahan CM, Proudfoot D, Farzaneh-Far A, and Weissberg PL (1998). The role of Gla proteins in vascular calcification. Critical Reviews™ in Eukaryotic Gene Expression, 8(3-4): 357-375.     
  28. Wetmur JG, Kaya AH, Plewinska M, and Desnick RJ (1991a). Molecular characterization of the human delta-aminolevulinate dehydratase 2 (ALAD2) allele: Implications for molecular screening of individuals for genetic susceptibility to lead poisoning. American Journal of Human Genetics, 49(4): 757–763. PMid:1716854 PMCid:PMC1683158     
  29. Wetmur JG, Lehnert G, and Desnick RJ (1991b). The δ-aminolevulinate dehydratase polymorphism: Higher blood lead levels in lead workers and environmentally exposed children with the 1–2 and 2-2 isozymes. Environmental Research, 56(2): 109-119. https://doi.org/10.1016/S0013-9351(05)80001-5 
  30. Zhang W, Leng S, Dai Y, and Wang Y (2003). Study on association of polymorphism of MGP (T-138C) gene and blood lead level in children. Wei sheng yan jiu= Journal of Hygiene Research, 32(6): 514-515.